Cite
HARVARD Citation
Lucas, M. et al. (n.d.). Anti-tumor activity of BDTX-1535, an irreversible CNS penetrant inhibitor of multiple EGFR extracellular domain alterations, in preclinical glioblastoma models. European journal of cancer. pp. S23-. [Online].